Yearly News Archives: 2009

Viamet Pharmaceuticals Secures $18M Financing

Company to Advance Development of Novel Metalloenzyme Inhibitors and Proprietary Metallophile™ Technology Platform Research Triangle Park, NC – Viamet Pharmaceuticals, Inc. announced today that it has secured $18 million in…